Author: Kang, Yu; Chen, Tiffany; Mui, David; Ferrari, Victor; Jagasia, Dinesh; Scherrer-Crosbie, Marielle; Chen, Yucheng; Han, Yuchi
Title: Cardiovascular manifestations and treatment considerations in covid-19 Cord-id: 5l513o55 Document date: 2020_4_30
ID: 5l513o55
Snippet: Since its recognition in December 2019, covid-19 has rapidly spread globally causing a pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular disease are associated with a greater severity and higher fatality rate of covid-19. Furthermore, covid-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest. The cardiov
Document: Since its recognition in December 2019, covid-19 has rapidly spread globally causing a pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular disease are associated with a greater severity and higher fatality rate of covid-19. Furthermore, covid-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest. The cardiovascular interactions of covid-19 have similarities to that of severe acute respiratory syndrome, Middle East respiratory syndrome and influenza. Specific cardiovascular considerations are also necessary in supportive treatment with anticoagulation, the continued use of renin-angiotensin-aldosterone system inhibitors, arrhythmia monitoring, immunosuppression or modulation, and mechanical circulatory support.
Search related documents:
Co phrase search for related documents- accelerated ageing and acute respiratory syndrome: 1, 2, 3
- accumulate evidence and acute respiratory syndrome: 1
- ace inhibitor and acei ace inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- ace inhibitor and acute coronary syndrome: 1
- ace inhibitor and acute heart failure: 1
- ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acei ace inhibitor and acute respiratory syndrome: 1, 2, 3
- acs acute coronary syndrome and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acs acute coronary syndrome and acute heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acs acute coronary syndrome and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acs acute coronary syndrome and additional study: 1
- activate immune cell and acute respiratory syndrome: 1
- active inflammation and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- acute coronary syndrome and additional study: 1
Co phrase search for related documents, hyperlinks ordered by date